Delivery Order SPE2DB22D1106-SPE2DB24FEVQ2
- Not listed
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $3,645.51 and a period of performance through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract, valued at $6,533.36, to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of the prescription drug WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The delivery order has a ceiling value of $2,194.16 and a period of performance through March 26, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which does not have a set-aside designation....
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a Delivery Order valued at $29,124.24 to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML prescription medication. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC allows DLA to efficiently procure...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,645.62 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC allows DLA to efficiently procure a comprehensive range of pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $3,324.85 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML medication. The contract has a period of performance through May 14, 2025 and is not set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,296.29, is for the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The order has a firm fixed price and is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a firm-fixed-price delivery order contract worth $6,565.30 for the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA Troop Support Medical to efficiently procure a comprehensive range of medical commodities to support military treatment programs and...
- The Defense Logistics Agency (DLA) has awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML. This $19,284.13 firm fixed price contract has a completion date of September 10, 2024. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, to provide a comprehensive range of medical commodities to support military treatment...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a potential value of $2,194.16 and a completion date of January 26, 2024. This award does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEVQ2Delivery Order
The U.S. government's Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp a delivery order contract worth $12,850.04 for the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's military treatment programs and facilities globally. The contract does not have a set-aside designation. As a major pharmaceutical distributor, Amerisourcebergen leverages its extensive supply chain network to efficiently deliver essential medical commodities to DLA facilities worldwide, supporting the agency's mission to provide logistics, acquisition, and technical services to the U.S. Armed Forces and other government entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.9k | 6/6/24 |